Literature DB >> 9926128

Diabetic ketoacidosis and clozapine.

D Ai1, T A Roper, J A Riley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9926128      PMCID： PMC2360894          DOI： 10.1136/pgmj.74.874.493

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  5 in total

1.  Ketoacidosis as a side-effect of clozapine: a case report.

Authors:  A E Kostakoğlu; K M Yazici; T Erbaş; N Güvener
Journal:  Acta Psychiatr Scand       Date:  1996-03       Impact factor: 6.392

2.  Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland.

Authors:  K Atkin; F Kendall; D Gould; H Freeman; J Liberman; D O'Sullivan
Journal:  Br J Psychiatry       Date:  1996-10       Impact factor: 9.319

3.  Diabetic ketoacidosis from clozapine and lithium cotreatment.

Authors:  G A Peterson; S L Byrd
Journal:  Am J Psychiatry       Date:  1996-05       Impact factor: 18.112

4.  Diabetic ketoacidosis associated with clozapine treatment.

Authors:  M S Koval; L J Rames; S Christie
Journal:  Am J Psychiatry       Date:  1994-10       Impact factor: 18.112

5.  Severe hyperglycemia associated with high doses of clozapine.

Authors:  A Kamran; P M Doraiswamy; J L Jane; E B Hammett; L Dunn
Journal:  Am J Psychiatry       Date:  1994-09       Impact factor: 18.112
  5 in total
  11 in total

1.  Simultaneous side effects of both clozapine and valproate.

Authors:  J Nicolai; S J Smith; R W Keunen
Journal:  Intensive Care Med       Date:  2001-05       Impact factor: 17.440

Review 2.  Atypical antipsychotics and diabetic ketoacidosis: a review.

Authors:  Melanie D Guenette; Margaret Hahn; Tony A Cohn; Celine Teo; Gary J Remington
Journal:  Psychopharmacology (Berl)       Date:  2013-01-24       Impact factor: 4.530

Review 3.  Atypical antipsychotic-induced diabetes mellitus: how strong is the evidence?

Authors:  David C Henderson
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 4.  Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.

Authors:  John W Newcomer
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 5.  Fatalities associated with therapeutic use and overdose of atypical antipsychotics.

Authors:  Adam Trenton; Glenn Currier; Frank Zwemer
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 6.  Diabetes mellitus and other metabolic disturbances induced by atypical antipsychotic agents.

Authors:  David C Henderson
Journal:  Curr Diab Rep       Date:  2002-04       Impact factor: 4.810

Review 7.  Hyperglycemia with antipsychotic treatment.

Authors:  Roopa Sathyaprakash; Robert R Henry
Journal:  Curr Diab Rep       Date:  2004-02       Impact factor: 4.810

Review 8.  Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management.

Authors:  Kimberly A Stigler; Marc N Potenza; David J Posey; Christopher J McDougle
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

Review 9.  Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications.

Authors:  Kristina Melkersson; Marja-Liisa Dahl
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 10.  Treatment of Diabetic Ketoacidosis Associated With Antipsychotic Medication: Literature Review.

Authors:  Antonia Vuk; Maja Baretic; Martina Matovinovic Osvatic; Igor Filipcic; Nikolina Jovanovic; Martina Rojnic Kuzman
Journal:  J Clin Psychopharmacol       Date:  2017-10       Impact factor: 3.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.